Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to antibody or antibody fragment or immunoglobulin;...
Patent
1975-04-30
1976-08-24
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to antibody or antibody fragment or immunoglobulin;...
23230B, 260112R, 424 12, 424 85, G01N 3300, A61K 3900
Patent
active
039767639
ABSTRACT:
A sensitive radioimmunoassay for chlorpromazine is described. To prepare the chlorpromazine selective antiserum, an antigen is made comprising chlorpromazine covalently bonded to an immunogenic carrier material through a diazo containing linking group and the antigen is injected into a suitable host mammal to elicit the desired antiserum. A preferred linking group is diazophenylcarbonyl while bovine serum albumin is a preferred immunogenic carrier material.
REFERENCES:
frey et al., Zentralblatt fuer Pharmazie, Pharmakotherapie und Labratorumsdiagnostic, vol. 113, No. 12, 1974, pp. 1279-1284.
Ekren et al., Nuclear Science Abstracts, vol. 28, No. 3, Aug. 15, 1973, abstract No. 6007, p. 570.
Glebov et al., Chemical Abstracts, vol. 71, No. 11, Sept. 15, 1969, abstract No. 47947v, p. 205.
Anisimor, Chemical Abstracts, vol. 68, No. 17, Apr. 22, 1968, abstract No. 76645p, p. 7387.
Gould George M.
Hoffmann-La Roche Inc.
Nucker Christine M.
Padgett Benjamin R.
Welt Samuel L.
LandOfFree
Chlorpromazine assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chlorpromazine assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlorpromazine assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-779422